Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ALGSALGS

2 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Aligos Therapeutics, Inc.

No. Qube Research & Technologies exited its ALGS (Aligos Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 10,947 shares worth $94,801. Qube Research & Technologies first reported ALGS in Q3 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$94,801

Total Shares Change

-10,947

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$39.84
0
2024-Q3
New
10,947
—
$94,8010.0%$8.04
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used